Literature DB >> 26620365

[Anaplastic large-cell lymphoma CD30(+) ALK(+)].

L Kollarikova1, M Heizerova2, M Simaljakova2.   

Abstract

We present a case of primary systemic anaplastic large-cell lymphoma, which manifested itself through skin involvement in a 32-year-old man. Only the third histological investigation with immunophenotyping resulted in the correct diagnosis of CD30(+) ALK(+) anaplastic large cell lymphoma. After combined chemotherapy and adjuvant radiotherapy, complete remission of the disease was achieved and one year after completion of therapy no relapse occurred. The diagnostic pitfalls and therapeutic options are discussed.

Entities:  

Keywords:  Chemotherapy; Histology; Immunophenotyping; Primary systemic lymphoma; Radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 26620365     DOI: 10.1007/s00105-015-3727-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

Review 1.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

Review 2.  Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.

Authors:  Toby A Eyre; Dalia Khan; Georgina W Hall; Graham P Collins
Journal:  Eur J Haematol       Date:  2014-05-21       Impact factor: 2.997

Review 3.  Common misdiagnoses in lymphomas and avoidance strategies.

Authors:  John K C Chan; Yok-Lam Kwong
Journal:  Lancet Oncol       Date:  2010-03-12       Impact factor: 41.316

4.  [Cutaneous malignant lymphomas. Update on diagnosis and therapy of cutaneous T-cell lymphomas].

Authors:  D Humme; M Möbs; S Pullmann; A Haidar; M Beyer; W Sterry; C Assaf
Journal:  Hautarzt       Date:  2012-05       Impact factor: 0.751

Review 5.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

6.  Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations.

Authors:  M Beylot-Barry; A Groppi; B Vergier; K Pulford; J P Merlio
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

7.  Tumour markers: An overview.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2007-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.